| CARVIEW |
Select Language
HTTP/2 200
date: Wed, 28 Jan 2026 03:39:58 GMT
content-type: text/html; charset=UTF-8
content-length: 31407
last-modified: Mon, 12 Jan 2026 10:32:34 GMT
etag: "4a467-6482e64a08eef-gzip"
content-encoding: gzip
x-frame-options: SAMEORIGIN
x-ws-id: 13
x-host: longevc.com
accept-ranges: bytes
x-tilda-server: 8
x-tilda-imprint: c325a9b0-6b07-4676-b03e-d80be0b59583
LongeVC | Backing Visionary Biotech — Portfolio 
portfolio companies
We are curating an ecosystem of biotech and longevity-focused companies ready to change the world. We facilitate connections for the companies we invest in, linking them with forward-thinking leaders and readily available growth prospects to drive their advancement.
fund II
Precision therapies engineered for change
Trogenix develops precision cancer treatments that selectively target diseased cell states and behavior, combining payloads that reveal cancer to the body’s immune system and kill tumor cells.
Trogenix develops precision cancer treatments that selectively target diseased cell states and behavior, combining payloads that reveal cancer to the body’s immune system and kill tumor cells.
Programmable systemic protein delivery
Stealth company develops durable in vivo biofactories that enable continuous production of therapeutic proteins in the body, starting with treatments for metabolic disorders.
Stealth company develops durable in vivo biofactories that enable continuous production of therapeutic proteins in the body, starting with treatments for metabolic disorders.
fund I
Novel therapeutics for personalized medicine
CatenaBio develops novel therapeutics by forming never-before-possible structures, which can modify and combine proteins with ease.
CatenaBio develops novel therapeutics by forming never-before-possible structures, which can modify and combine proteins with ease.
Rewriting biology for new possibilities
Constructive Bio combines world-leading genome synthesis and engineered translation technologies to unlock enhanced organisms and create next-gen protein therapeutics, biopolymers, and materials.
Constructive Bio combines world-leading genome synthesis and engineered translation technologies to unlock enhanced organisms and create next-gen protein therapeutics, biopolymers, and materials.
Rejuvenating cells
Turn.bio is developing mRNA medicines formulated to instruct specific cells in the body to fight disease or repair damaged tissue.
Turn.bio is developing mRNA medicines formulated to instruct specific cells in the body to fight disease or repair damaged tissue.
First ever on-demand potassium monitoring
ProtonIntel is developing a continuous wearable kidney health monitoring platform, an innovation with the potential to transform patient care in critical medical scenarios.
ProtonIntel is developing a continuous wearable kidney health monitoring platform, an innovation with the potential to transform patient care in critical medical scenarios.
Therapeutics to preserve biological youth
Rubedo Life Sciences is developing therapeutics to target senescent cells that contribute to age-related diseases.
Rubedo Life Sciences is developing therapeutics to target senescent cells that contribute to age-related diseases.
A new logic to treating cancer cells
Valink Therapeutics is developing a series of novel therapeutics that are more effective at attacking tumours, while sparing healthy tissue.
Valink Therapeutics is developing a series of novel therapeutics that are more effective at attacking tumours, while sparing healthy tissue.
Defensive co-scaling for biology
Red Queen Bio is an AI biosecurity company working with frontier labs to map AI-enabled biothreats and pre-build medical countermeasures against them.
Red Queen Bio is an AI biosecurity company working with frontier labs to map AI-enabled biothreats and pre-build medical countermeasures against them.
New understanding of biology and diseases
Glyphic Biotechnologies is developing a protein sequencing platform that can decode the human proteome using single-molecule, massively parallel technology.
Glyphic Biotechnologies is developing a protein sequencing platform that can decode the human proteome using single-molecule, massively parallel technology.
Funding the future of longevity research
The Longevity Science Foundation is an international non-profit funding early-stage research on extending the healthy human lifespan.
The Longevity Science Foundation is an international non-profit funding early-stage research on extending the healthy human lifespan.
Reversing skin ageing
Medici Therapeutics deploys genetic solutions to solve skin ageing at the molecular level.
Medici Therapeutics deploys genetic solutions to solve skin ageing at the molecular level.
Discovering new drugs with AI
Insilico Medicine applies generative AI to discover new treatments for COVID-19, pulmonary disease and other conditions.
Insilico Medicine applies generative AI to discover new treatments for COVID-19, pulmonary disease and other conditions.
Pioneering pet longevity
Basepaws. Different breeds, different needs. Every cat is unique. Get to know your cat's health and behavior better with a feline DNA Test.
Basepaws. Different breeds, different needs. Every cat is unique. Get to know your cat's health and behavior better with a feline DNA Test.
Measuring your biological age
Deep Longevity provides a SaaS solution integrating multiple biomarkers of aging dubbed "deep aging clocks" to provide a comprehensive and universal measure of human biological age.
Deep Longevity provides a SaaS solution integrating multiple biomarkers of aging dubbed "deep aging clocks" to provide a comprehensive and universal measure of human biological age.
Engaging patients in clinical trials
Longenesis builds software that makes it easier for patients and study organizers to collect, analyze, and manage medical data.
Longenesis builds software that makes it easier for patients and study organizers to collect, analyze, and manage medical data.
Powering the longevity industry
First Longevity brings together innovators and investors to support the companies that will form the longevity economy. Longevity.Technology is the industry's leading media outlet.
First Longevity brings together innovators and investors to support the companies that will form the longevity economy. Longevity.Technology is the industry's leading media outlet.
Detecting ovarian cancer with blood tests
AOA Dx is developing the first accurate early-stage non-invasive ovarian cancer diagnostic test that will improve clinical practice, reduce patient mortality and deliver cost savings.
AOA Dx is developing the first accurate early-stage non-invasive ovarian cancer diagnostic test that will improve clinical practice, reduce patient mortality and deliver cost savings.
Personalizing cancer treatments
PreComb leverages artificial intelligence to test cancer treatments on genetically identical tumor sample twins.
PreComb leverages artificial intelligence to test cancer treatments on genetically identical tumor sample twins.
Improving newborn infection diagnosis
Melio provides an advanced diagnostic platform to detect pathogens faster and more effectively than existing solutions.
Melio provides an advanced diagnostic platform to detect pathogens faster and more effectively than existing solutions.
Delivering new mental health approaches
Freedom Biosciences is developing cutting-edge ketamine therapies for treatment-resistant depression.
Freedom Biosciences is developing cutting-edge ketamine therapies for treatment-resistant depression.
Unlocking your personal health
SiPhox Health provides cutting-edge at-home health testing offering insights into cardiovascular health, metabolism, hormones, and more.
SiPhox Health provides cutting-edge at-home health testing offering insights into cardiovascular health, metabolism, hormones, and more.
Powering AI-enabled analytics for skincare
Haut.AI offers personalized wellness tools that empower users to make better skin and body health choices.
Haut.AI offers personalized wellness tools that empower users to make better skin and body health choices.
Mapping whole-organism coherence
Ani.AI develops a biological state model that views the body as an integrated network. The platform identifies patterns connecting everyday signals to molecular changes, allowing for continuous assessment of system stability.
Ani.AI develops a biological state model that views the body as an integrated network. The platform identifies patterns connecting everyday signals to molecular changes, allowing for continuous assessment of system stability.
Leveraging bacteria for drug discovery
Interface Biosciences is a drug discovery company developing platform to identify metabolites derived from microorganisms to treat a range of diseases, starting from atopic dermatitis.
Interface Biosciences is a drug discovery company developing platform to identify metabolites derived from microorganisms to treat a range of diseases, starting from atopic dermatitis.
Unlocking undruggable targets
Unnatural Products is pairing ML with chemistry and leveraging the power of macrocycles to create treatments for undruggable or hard-to-reach drug targets.
Unnatural Products is pairing ML with chemistry and leveraging the power of macrocycles to create treatments for undruggable or hard-to-reach drug targets.
Advanced mRNA platform
Helix Nanotechnologies is building the world's most advanced mRNA platform to enable previously impossible applications across human and non-human biology.
Helix Nanotechnologies is building the world's most advanced mRNA platform to enable previously impossible applications across human and non-human biology.
Advancing the longevity industry
The Longevity Biotech Association is a consortium aiming to advance the longevity industry by setting standards, educating stakeholders, and encouraging partnerships.
The Longevity Biotech Association is a consortium aiming to advance the longevity industry by setting standards, educating stakeholders, and encouraging partnerships.
Washington D.C., US
The Future Belongs to Biotech Founders
© All Rights Reserved, 2026
© All Rights Reserved, 2026
get in touch
social
newsletter
subscribe to LongeVC